Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation

By Bhatia R.   Munthe H.A.   Williams A.D.   Zhang F.   Forman S.J.   Slovak M.L.  

Experimental Hematology, Vol. 28, Iss. 12, 2000-12 ,pp. : 1401-1412

Elsevier

Access to resources Recommend Favorite

Contact with fibronectin enhances preservation of normal but not chronic myelogenous leukemia primitive hematopoietic progenitors

By Bhatia R.   Williams A.D.   Munthe H.A.  

Experimental Hematology, Vol. 30, Iss. 4, 2002-04 ,pp. : 324-332

Elsevier

Access to resources Recommend Favorite

Blockade of 4 1-Integrin-Fibronectin Adhesive Interactions Prevents Chronic Allograft Rejection in Sensitized Recipients

By Coito A.J.   Korom S.   Hancock W.W.   Kupiec-Weglinski J.W.  

Transplantation Proceedings, Vol. 30, Iss. 4, 1998-06 ,pp. : 939-940

Elsevier

Access to resources Recommend Favorite

Acute myelogenous leukemia—microenvironment interactions: Role of endothelial cells and proteasome inhibition

By Liesveld Jane L.   Rosell Karen E.   Lu Chaohui   Bechelli Jeremy   Phillips II Gordon   Lancet Jeffrey E.   Abboud Camille N.  

Hematology, Vol. 10, Iss. 6, 2005-12 ,pp. : 483-494

Maney Publishing

Access to resources Recommend Favorite

Novel therapies for chronic myelogenous leukemia

By Jahagirdar B.N.   Miller J.S.   Shet A.   Verfaillie C.M.  

Experimental Hematology, Vol. 29, Iss. 5, 2001-05 ,pp. : 543-556

Elsevier

Access to resources Recommend Favorite